GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Novartis NOVN.SW · CHF

Health Care · Pharmaceuticals · SIX · 🇨🇭 Switzerland

Compare

133.46

+0.29%

Close of 9 Nov 2026, in CHF

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Novartis — daily SIX:NOVN End of day
Market value
CHF 253.67bn
Last close × shares
Volume
2.2m
Shares, 9 Nov 2026
Price to earnings
28.2
Dividend yield
2.75%

About Novartis

Its shares trade on SIX under the ticker NOVN.SW. It has been listed since 7 May 2001. In the fiscal year to 31 December 2025, it reported revenue of $46.49bn and net income of $11.92bn. At that date it held total assets of $94.00bn and shareholders' equity of $37.52bn.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. The company is headquartered in Basel, Basel-Stadt. The company went IPO on 2001-05-07. The firm develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The firm uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

Figures and description from our data supplier, not checked against the company's own report.

More about Novartis →

Latest on Novartis

Our reporting

Next results

3 Feb 2027

Due on 3 Feb 2027. Analysts expect earnings of 1.84 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Novartis's ticker?

Novartis trades as NOVN.SW on SIX, under ISIN CH0012005267.

What was Novartis's last closing price?

133.46 on 9 Nov 2026. The figure is in CHF and is never converted.

When does Novartis next report results?

Results are expected on 3 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.